Daniel Tasse

Insider Reports History

Location: C/O Ikaria, Inc., 6 State Route 173, Clinton, NJ
Signature: /s/ Patrick J. Christmas as attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Tasse:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
REGENXBIO Inc.	Director	Common Stock	19.1K	$152K	$7.97	May 30, 2025	Direct
DBV Technologies S.A.	CHIEF EXECUTIVE OFFICER, Director	Ordinary Shares	17.1K	$14.2K	$0.83	Mar 8, 2024	Direct
DBV Technologies S.A.	CHIEF EXECUTIVE OFFICER, Director	Employee Stock Option (right to buy)	813K			Dec 4, 2024	Direct
REGENXBIO Inc.	Director	Stock Options (Right to Buy)	39.8K			May 30, 2025	Direct
REGENXBIO Inc.	Director	Stock Options (Right to Buy)	24.5K			May 31, 2024	Direct

Showing 1 to 5 of 5 entries

Insider Reports Filed by Daniel Tasse

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
RGNX	REGENXBIO Inc.	May 30, 2025	2	$0	4	Jun 3, 2025	Director
DBVT	DBV Technologies S.A.	Dec 4, 2024	1	$0	4	Dec 5, 2024	CHIEF EXECUTIVE OFFICER, Director
RGNX	REGENXBIO Inc.	May 31, 2024	2	$0	4	Jun 4, 2024	Director
DBVT	DBV Technologies S.A.	Mar 8, 2024	1	$14.2K	4	Mar 11, 2024	CHIEF EXECUTIVE OFFICER, Director
DBVT	DBV Technologies S.A.	Nov 20, 2023	1	$0	4	Nov 22, 2023	Chief Executive Officer, Director
RGNX	REGENXBIO Inc.	Jun 2, 2023	2	$0	4	Jun 6, 2023	Director
DBVT	DBV Technologies S.A.	Nov 21, 2022	1	$0	4	Aug 14, 2023	Chief Executive Officer, Director
RGNX	REGENXBIO Inc.	Jun 3, 2022	2	$0	4	Jun 7, 2022	Director
DBVT	DBV Technologies S.A.	Nov 22, 2021	1	$0	4	Nov 24, 2021	Chief Executive Officer, Director
RGNX	REGENXBIO Inc.	Jun 4, 2021	1	$0	4	Jun 8, 2021	Director